Kaiseraugst (Switzerland), Heerlen (Netherlands), October 26, 2023
dsm-firmenich announces the upcoming commissioning of a brand-new Habanolide® facility at its production site in southwest France. The new state-of-the-art facility will significantly increase the production capacity of this iconic perfume ingredient and help meet the rapidly growing demand for sustainable products. The new production facility will be operational in January 2024.
“This is our first Habanolide® production unit in Europe,” says Emmanuel Butstraen, President Perfumery & Beauty at dsm-firmenich. “It will further strengthen our strategic position and enable us to offer additional capabilities for perfumery production in the region. In addition to helping us capture the growth opportunities that lie ahead, it will also contribute to lowering the carbon footprint of our logistics operations. We’ll be able to provide an enhanced service close to our customers in Europe and help them deliver on their own sustainability goals by reducing their scope 3 emissions.”
Spanning across four levels, the new facility will feature cutting-edge technologies ensuring the highest safety standards, operational stability, quality, energy efficiency, and reduced water consumption. The entire project is being completed by a dozen local companies, who have been engaging around 40 subcontractors daily for the past year.
“We are very proud of this new production unit, designed to increase the supply of this biodegradable and powerful musk which is one of our best-selling ingredients,” adds Amaury Roquette, Head of Ingredients, Perfumery & Beauty at dsm-firmenich. “This facility will allow us to produce Habanolide® in Europe, in addition to the production line in New Jersey, US. With this additional project, we are strengthening our global leadership in musk ingredients.”
Habanolide® is an elegant macrocyclic musk with a warm and slightly woody note. It is a key ingredient in the company’s industry-leading palette, and extremely popular in combination with dsm-firmenich’s renewable musks such as Helvetolide® and Romandolide®, as well as with the recently introduced captive ingredients Sorbettolide® and Casmiwood®. This capacity increase will also benefit the Habanolide® derivatives Exaltolide Total® and Exaltolide®.
dsm-firmenich has a strong legacy in the production of musk ingredients. Years of dedication to research and development have positioned the company as a market pioneer, earning it global recognition as the ‘House of Musk’.
This expansion project received €1million in support from the national recovery plan implemented by the French government and the regional authorities of Nouvelle Aquitaine to accelerate industrial investments in France.
For more information:
dsm-firmenich media enquiries:
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.